Archives
-
NAD+ in Stress-Response Assays
2026-09-20
Explore how Nicotinamide Adenine Dinucleotide (NAD+) can sharpen interpretation of autophagy, PARP1, and DNA-damage assays. This article connects NAD+ biochemistry with new evidence on non-lethal caspase signaling while separating established findings from experimental hypotheses.
-
Cholesterol in Translational mRNA-LNP Strategy
2026-09-19
Cholesterol is more than a membrane excipient: it is a tunable design variable for mRNA-LNP stability, delivery, and translational reproducibility. This thought-leadership article connects cholesterol biology with the intravesical p21 mRNA-LNP bladder cancer study and outlines practical formulation, assay, and development priorities.
-
Saquinavir Workflows for HIV Protease Research
2026-09-18
Use Saquinavir as a controlled HIV protease inhibitor benchmark while connecting enzymatic potency with membrane interaction and permeability measurements. This workflow combines practical stock handling, biomimetic chromatography, mass spectrometry, and troubleshooting for reproducible antiretroviral drug research.
-
Nanoparticle mRNA Delivery Reverses Trastuzumab Resistance
2026-09-18
The reference study developed a tumor-microenvironment-responsive nanoparticle for systemic delivery of PTEN mRNA in trastuzumab-resistant HER2-positive breast cancer. By restoring PTEN and suppressing persistently active PI3K/Akt signaling, the platform improved trastuzumab responsiveness and reduced tumor progression in preclinical models.
-
Apigenin: From HDAC Biology to Network Medicine
2026-09-17
Apigenin connects epigenetic tumor biology with network-based neuroprotection. This thought-leadership guide interprets the evidence, defines practical assay parameters, and outlines a translational strategy for researchers studying malignant mesothelioma, Alzheimer’s disease, apoptosis, inflammation, and oxidative stress.
-
circHIF1A/miR-486-5p/GRHL2 in LUAD
2026-09-17
The reference study identifies a circHIF1A/miR-486-5p/GRHL2 regulatory axis that links malignant behavior in lung adenocarcinoma cells with IL-10-associated macrophage M2 polarization. Its combination of patient tissues, cell models, and xenografts supports circHIF1A as a candidate prognostic biomarker and a mechanistic entry point for studying tumor–immune interactions.
-
MRT68921: A Practical ULK1 Kinase Inhibitor Workflow
2026-09-16
MRT68921 enables direct, dual ULK1/2 inhibition for separating autophagy-initiation effects from broader energy-stress signaling. This workflow combines ATG13 phosphorylation blockade, LC3 flux measurement, genetic controls, and nutrient-stress designs to improve mechanistic confidence in preclinical assays.
-
FK866 (APO866) Workflow for NAD Studies
2026-09-16
FK866 (APO866) provides a precise way to deplete intracellular NAD and connect NAMPT activity with ATP loss, mitochondrial stress, and selective cancer-cell death. This workflow emphasizes AML model selection, orthogonal readouts, practical dosing, and careful translation of NAMPT findings from vascular-aging research.
-
Nanoparticle mRNA Delivery Reverses Trastuzumab Resistance
2026-09-15
The reference study developed tumor-microenvironment pH-responsive nanoparticles for systemic delivery of PTEN mRNA, targeting PI3K/Akt pathway activity in trastuzumab-resistant HER2-positive breast cancer. Its main contribution is a coordinated delivery strategy that combines prolonged circulation, tumor-triggered uptake, and restoration of a tumor-suppressive signal, although translation beyond experimental models requires further validation.
-
MPA as a Translational Probe of Steroid Signaling
2026-09-15
Medroxyprogesterone acetate is more than a synthetic progestin: it is a mechanistic probe for separating progesterone receptor, glucocorticoid receptor, and tissue-specific signaling. This article connects MPA with renal, neuroendocrine, and endometrial models while using vitamin D/VDR findings to build a stronger translational experimental strategy.
-
CPI-613 Workflows for Tumor Cell Metabolism
2026-09-14
Build reproducible mitochondrial metabolism experiments around CPI-613, from dose–response and apoptosis assays to chemotherapy-sensitization studies. The workflow also translates PDHA1-centered findings in cholangiocarcinoma into practical tumor–macrophage assay designs while clearly separating established evidence from optimization recommendations.
-
Caspase 3/7 Link Stress Adaptation to Autophagy
2026-09-14
Samarasekera et al. demonstrate that caspase 3 and caspase 7 have non-apoptotic, cytoprotective functions during non-lethal stress in human breast cancer cells. Their findings connect effector caspases with autophagy, PARP1 regulation, DNA damage signaling, and synthetic lethality with BRCA1 loss, providing a mechanistic framework for future cancer-cell stress studies.
-
HyperScribe T7 High Yield Cy5 RNA Labeling Kit
2026-09-13
The HyperScribe T7 High Yield Cy5 RNA Labeling Kit is a Cy5 RNA labeling kit for generating fluorescent RNA probes by T7-driven in vitro transcription. Its adjustable Cy5-UTP substitution supports a practical balance between RNA yield and labeling efficiency for hybridization workflows.
-
TRIM21–ERK1/2 Signaling in Pituitary Adenomas
2026-09-12
Liu and colleagues identify TRIM21 as a regulator of pituitary adenoma proliferation and therapeutic resistance, linking its E3-ligase activity to K27-linked ubiquitination and phosphorylation of ERK1/2. The study also uses drug screening to nominate HDAC-directed compounds that reduce TRIM21, providing a mechanistic rationale for investigating epigenetic modulation alongside dopamine-agonist treatment.
-
HyperScribe T7 Cy5 RNA Labeling Kit Guide
2026-09-11
The HyperScribe T7 High Yield Cy5 RNA Labeling Kit is a 25-reaction system for tunable fluorescent RNA probe synthesis by T7-mediated in vitro transcription. Its adjustable Cy5-UTP substitution supports both in situ hybridization probe preparation and Northern blot hybridization probe workflows.